Latest Insider Transactions at Vanda Pharmaceuticals Inc. (VNDA)
This section provides a real-time view of insider transactions for Vanda Pharmaceuticals Inc. (VNDA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Vanda Pharmaceuticals Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Vanda Pharmaceuticals Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 29
2024
|
Kevin Patrick Moran SVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
2,251
-0.97%
|
$11,255
$5.92 P/Share
|
|
May 22
2024
|
Phaedra Chrousos |
BUY
Grant, award, or other acquisition
|
Direct |
21,887
+25.45%
|
-
|
|
May 17
2024
|
Tage Honore |
BUY
Grant, award, or other acquisition
|
Direct |
20,529
+24.22%
|
-
|
|
May 17
2024
|
Anne Sempowski Ward |
BUY
Grant, award, or other acquisition
|
Direct |
20,529
+25.54%
|
-
|
|
May 17
2024
|
Stephen Ray Mitchell |
BUY
Grant, award, or other acquisition
|
Direct |
20,529
+29.17%
|
-
|
|
May 17
2024
|
Richard W Dugan |
BUY
Grant, award, or other acquisition
|
Direct |
20,529
+14.79%
|
-
|
|
Mar 05
2024
|
Timothy Williams SVP & General Counsel |
SELL
Open market or private sale
|
Direct |
8,941
-4.35%
|
$35,764
$4.18 P/Share
|
|
Mar 05
2024
|
Gunther Birznieks SVP, Business Development |
SELL
Open market or private sale
|
Direct |
8,684
-2.69%
|
$34,736
$4.13 P/Share
|
|
Mar 05
2024
|
Kevin Patrick Moran SVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
8,902
-3.71%
|
$35,608
$4.2 P/Share
|
|
Mar 05
2024
|
Mihael Hristos Polymeropoulos President and CEO |
SELL
Open market or private sale
|
Direct |
24,288
-1.28%
|
$97,152
$4.13 P/Share
|
|
Mar 05
2024
|
Joakim Wijkstrom SVP, Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
9,229
-6.64%
|
$36,916
$4.21 P/Share
|
|
Mar 04
2024
|
Timothy Williams SVP & General Counsel |
SELL
Open market or private sale
|
Direct |
8,147
-3.81%
|
$32,588
$4.41 P/Share
|
|
Mar 04
2024
|
Gunther Birznieks SVP, Business Development |
SELL
Open market or private sale
|
Direct |
8,727
-2.64%
|
$34,908
$4.3 P/Share
|
|
Mar 04
2024
|
Kevin Patrick Moran SVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
5,798
-2.36%
|
$23,192
$4.48 P/Share
|
|
Mar 04
2024
|
Mihael Hristos Polymeropoulos President and CEO |
SELL
Open market or private sale
|
Direct |
30,884
-1.6%
|
$123,536
$4.24 P/Share
|
|
Mar 04
2024
|
Joakim Wijkstrom SVP, Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
7,498
-5.12%
|
$29,992
$4.41 P/Share
|
|
Feb 16
2024
|
Timothy Williams SVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+36.88%
|
-
|
|
Feb 16
2024
|
Gunther Birznieks SVP, Business Development |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+27.41%
|
-
|
|
Feb 16
2024
|
Mihael Hristos Polymeropoulos President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
450,000
+18.93%
|
-
|
|
Feb 16
2024
|
Kevin Patrick Moran SVP, CFO & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+33.72%
|
-
|
|
Feb 16
2024
|
Joakim Wijkstrom SVP, Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,700
+18.25%
|
-
|
|
Aug 21
2023
|
Joakim Wijkstrom SVP, Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
3,724
-3.17%
|
$18,620
$5.84 P/Share
|
|
Aug 10
2023
|
Stephen Ray Mitchell |
SELL
Open market or private sale
|
Direct |
6,500
-18.14%
|
$39,000
$6.05 P/Share
|
|
Jul 28
2023
|
Kevin Patrick Moran SVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
2,212
-0.9%
|
$13,272
$6.3 P/Share
|
|
Jun 15
2023
|
Kevin Patrick Moran SVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
16,000
-11.52%
|
$96,000
$6.29 P/Share
|
|
Jun 13
2023
|
Timothy Williams SVP & General Counsel |
SELL
Open market or private sale
|
Direct |
14,600
-14.1%
|
$87,600
$6.56 P/Share
|
|
Jun 08
2023
|
Stephen Ray Mitchell |
BUY
Grant, award, or other acquisition
|
Direct |
17,307
+32.57%
|
-
|
|
Jun 08
2023
|
Anne Sempowski Ward |
BUY
Grant, award, or other acquisition
|
Direct |
17,307
+30.57%
|
-
|
|
Jun 08
2023
|
Phaedra Chrousos |
BUY
Grant, award, or other acquisition
|
Direct |
17,307
+29.07%
|
-
|
|
Jun 08
2023
|
Richard W Dugan |
BUY
Grant, award, or other acquisition
|
Direct |
17,307
+15.05%
|
-
|
|
Jun 08
2023
|
Tage Honore |
BUY
Grant, award, or other acquisition
|
Direct |
17,307
+28.36%
|
-
|
|
Mar 15
2023
|
Tage Honore |
BUY
Grant, award, or other acquisition
|
Direct |
26,408
+50.0%
|
-
|
|
Mar 03
2023
|
Gunther Birznieks SVP, Business Development |
SELL
Open market or private sale
|
Direct |
8,268
-3.86%
|
$49,608
$6.26 P/Share
|
|
Mar 03
2023
|
Kevin Patrick Moran SVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
5,968
-4.12%
|
$35,808
$6.28 P/Share
|
|
Mar 03
2023
|
Mihael Hristos Polymeropoulos President and CEO |
SELL
Open market or private sale
|
Direct |
22,538
-1.5%
|
$135,228
$6.25 P/Share
|
|
Mar 03
2023
|
Joakim Wijkstrom SVP, Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
4,113
-3.38%
|
$24,678
$6.32 P/Share
|
|
Mar 03
2023
|
Timothy Williams SVP & General Counsel |
SELL
Open market or private sale
|
Direct |
8,301
-7.42%
|
$49,806
$6.25 P/Share
|
|
Mar 02
2023
|
Gunther Birznieks SVP, Business Development |
SELL
Open market or private sale
|
Direct |
8,509
-3.82%
|
$51,054
$6.2 P/Share
|
|
Mar 02
2023
|
Kevin Patrick Moran SVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
7,966
-5.21%
|
$47,796
$6.26 P/Share
|
|
Mar 02
2023
|
Mihael Hristos Polymeropoulos President and CEO |
SELL
Open market or private sale
|
Direct |
22,426
-1.47%
|
$134,556
$6.23 P/Share
|
|
Mar 02
2023
|
Joakim Wijkstrom SVP, Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
7,720
-5.97%
|
$46,320
$6.23 P/Share
|
|
Mar 02
2023
|
Timothy Williams SVP & General Counsel |
SELL
Open market or private sale
|
Direct |
8,437
-7.02%
|
$50,622
$6.24 P/Share
|
|
Feb 16
2023
|
Mihael Hristos Polymeropoulos President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
115,000
+7.03%
|
-
|
|
Feb 16
2023
|
Joakim Wijkstrom SVP, Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,700
+20.18%
|
-
|
|
Feb 16
2023
|
Timothy Williams SVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
32,700
+21.38%
|
-
|
|
Feb 16
2023
|
Gunther Birznieks SVP, Business Development |
BUY
Grant, award, or other acquisition
|
Direct |
32,700
+12.8%
|
-
|
|
Feb 16
2023
|
Kevin Patrick Moran SVP, CFO & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
32,700
+17.62%
|
-
|
|
Dec 15
2022
|
Timothy Williams SVP & General Counsel |
SELL
Open market or private sale
|
Direct |
8,000
-8.37%
|
$56,000
$7.01 P/Share
|
|
Dec 06
2022
|
Kevin Patrick Moran SVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
4,792
-3.84%
|
$47,920
$10.61 P/Share
|
|
Dec 06
2022
|
Kevin Patrick Moran SVP, CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+5.66%
|
$22,500
$3.12 P/Share
|